跳至主要内容
临床试验/NCT07551310
NCT07551310已完成不适用

Immunohistochemical Evaluation of Lymphocyte Subpopulations in Peripheral Giant Cell Granuloma and Healthy Gingival Tissues: A Within-Subject Controlled Study

Ataturk University1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2026年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
28
试验地点
1
主要终点
Proportion of Lymphocyte Subpopulations

研究概览

简要总结

Peripheral giant cell granuloma (PGCG) is a non-neoplastic inflammatory lesion of gingival tissues. This study aims to evaluate and compare lymphocyte subpopulations in PGCG tissues and adjacent healthy gingival tissues obtained from the same individuals.

A total of 28 systemically healthy, non-smoking patients diagnosed with PGCG are included in this study. Biopsy samples are collected during surgical excision of PGCG lesions, and corresponding healthy gingival tissues are obtained from the same patients.

Immunohistochemical analysis is performed to assess lymphocyte subpopulations, including CD3, CD4, CD8, CD20, and CD79a. The proportions of these cells are compared between diseased and healthy tissues.

详细描述

Peripheral giant cell granuloma (PGCG) is a relatively common non-neoplastic inflammatory lesion of the gingiva characterized by multinucleated giant cells within a vascularized stroma. Lymphocyte subpopulations, including T- and B-cells, play a significant role in the immunopathogenesis of gingival and periodontal diseases.

The evaluation of lymphocyte subpopulations in gingival tissues is an established method for understanding local immune responses. However, limited data are available regarding lymphocyte profiles in PGCG lesions. Therefore, this study aims to investigate and compare lymphocyte subpopulations in PGCG and healthy gingival tissues.

This study is designed as a within-subject controlled observational study including 28 systemically healthy and non-smoking patients diagnosed with PGCG. Biopsy samples are obtained from PGCG lesions during surgical excision, and corresponding healthy gingival tissues are collected from the same individuals.

Tissue specimens are processed using standard histological procedures and analyzed by immunohistochemical methods. The presence and proportion of CD3, CD4, CD8, CD20, and CD79a positive cells are evaluated. The proportion of positively stained cells is calculated as the percentage of positive cells relative to the total number of counted cells.

The results are compared between PGCG tissues and healthy gingival tissues to identify differences in lymphocyte subpopulations and to better understand the immunopathological characteristics of PGCG.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Systemically healthy individuals
  • Non-smokers
  • Patients diagnosed with peripheral giant cell granuloma
  • Individuals requiring surgical excision of PGCG
  • Patients providing written informed consent

排除标准

  • Presence of systemic diseases
  • Smoking habit
  • Use of medications associated with gingival enlargement
  • History of periodontal treatment within the last 6 months
  • Pregnant or lactating individuals

研究组 & 干预措施

PGCG Tissue

Biopsy samples obtained from peripheral giant cell granuloma lesions during surgical excision.

干预措施: Immunohistochemical Analysis (Diagnostic Test)

Healthy Gingival Tissue

Biopsy samples obtained from adjacent healthy gingival tissues of the same patients.

干预措施: Immunohistochemical Analysis (Diagnostic Test)

结局指标

主要结局

Proportion of Lymphocyte Subpopulations

时间窗: At the time of tissue analysis (baseline)

The proportion of CD3, CD4, CD8, CD20, and CD79a positive cells is determined by calculating the percentage of positively stained cells relative to the total number of counted cells in gingival tissue samples.

次要结局

  • CD4/CD8 Ratio(At the time of tissue analysis (baseline))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alparslan Dilsiz

Principal Investigator

Ataturk University

研究点 (1)

Loading locations...

相似试验

Lymphocyte Subpopulations in Peripheral Giant Cell... | 临床试验